Roy Vitkon (N Keren-Khadmy)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Acute Lymphoblastic Leukemia

Prognostic Factors

Acute Kidney Injury

Multiple Myeloma

Top Venues

Journal of clinical medicine

Therapeutic advances in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Or Atar, Ron Ram, Irit Avivi, Odelia Amit, Roy Vitkon, Efrat Luttwak, Yael Bar-On, Yori Gidron
Vagal Nerve Activity Predicts Prognosis in Diffused Large B-Cell Lymphoma and Multiple Myeloma. Journal of clinical medicine 12 (3) (2023)
Or Atar, Ron Ram, Irit Avivi, Odelia Amit, Roy Vitkon, Efrat Luttwak, Yael Bar-On, Yori Gidron
Vagal Nerve Activity Predicts Prognosis in Diffused Large B-Cell Lymphoma and Multiple Myeloma. Journal of clinical medicine 12 (3) (2023)
Or Atar, Ron Ram, Irit Avivi, Odelia Amit, Roy Vitkon, Efrat Luttwak, Yael Bar-On, Yori Gidron
Vagal Nerve Activity Predicts Prognosis in Diffused Large B-Cell Lymphoma and Multiple Myeloma. Journal of clinical medicine 12 (3) (2023)
Roy Vitkon, Dan Netanely, Shai Levi, Tomer Ziv-Baran, Ronit Ben-Yzak, Ben-Zion Katz, Noam Benyamini, Svetlana Trestman, Moshe Mittelman, Yael Cohen, Irit Avivi
Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study. Therapeutic advances in hematology 12 (2021)
C Perry, E Luttwak, Efrat Luttwak, G Shefer, M M Morales, Miguel Morales Moshiashvili, Y Tabib, Y C Cohen, N Benyamini, O Beyar-Katz, M Neaman, R Vitkon, Roy Vitkon, Noa Keren-Khadmy, Maya Levin, I Avivi
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma. Blood advances 5 (16) (2021)